On-Demand Webinar: A Landmark Achievement That Will Broaden Research
Overview
The use of organoids to model human development in health and disease has reached unprecedented levels of interest. A pioneering team from the U.K. has recently demonstrated a groundbreaking achievement: progenitor cells from amniotic fluid, known as tissue-specific stem cells (distinct from pluripotent stem cells), can successfully form fetal organoids. These researchers have developed organoids of various tissue types, including the small intestine, kidney, and lung, using cells collected from amniotic fluid samples—without the need for fetal tissue or pregnancy termination.
In this exclusive GEN keynote webinar, join Mattia Gerli, PhD, and Paolo De Coppi, MD, from the University College London, Institute of Child Health, as they unveil the methods and insights behind this landmark research. Dr. De Coppi, a pediatric surgeon at Great Ormond Street Hospital and head of stem cells and regenerative medicine at University College London, specializes in congenital malformations. Together with Dr. Gerli, they will share their perspectives on how these organoids can enhance our understanding of development during later-stage pregnancies and propel research into congenital anomalies.
- Document type: On-demand webinar
- Watch time: 51 minutes
What you will learn:
- The innovative techniques used to develop fetal organoids from amniotic fluid progenitor cells.
- The potential applications of these organoids in understanding human development and congenital anomalies.
- Insights into the future of organoid research and its implications for regenerative medicine.
Webinar Speakers
Paolo De Coppi, MD
Pediatric Surgeon and Head of Stem Cells and Regenerative Medicine
UCL Great Ormond Street Institute of Child Health
Mattia Gerli, PhD
Lecturer in Stem Cell Science & Biomaterials
Faculty of Medical Sciences at the UCL
